Dael, Mary F.

HRN: 23-50-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
METRONIDAZOLE 500MG (TAB)
07/29/2025
08/05/2025
PO
500mg
TID
NSVD Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: